Related Experiment Videos
Uterine artery embolisation for symptomatic fibroids.
R W Dover1, H W Torode, G M Briggs
1Royal North Shore Hospital, Sydney, NSW.
The Medical Journal of Australia
|April 25, 2000
Summary
Uterine artery embolisation offers symptomatic relief for fibroids, significantly reducing pelvic pressure in most women. While uterine volume reduction varies, this minimally invasive option presents an alternative to traditional surgery.
Area of Science:
- Interventional Radiology
- Gynecologic Surgery
- Vascular Embolisation
Background:
- Traditional surgical treatments for symptomatic fibroids, such as hysterectomy and myomectomy, are associated with significant morbidity.
- Endoscopic surgery offers reduced morbidity but is not widely available and has limitations.
Purpose of the Study:
- To evaluate the efficacy and outcomes of uterine artery embolisation (UAE) for treating symptomatic uterine fibroids.
- To compare UAE with traditional surgical interventions for fibroid management.
Main Methods:
- Pelvic vasculature embolisation, a technique used for postpartum bleeding, was adapted for symptomatic fibroids.
- Uterine artery embolisation was performed, and uterine volume changes and symptomatic relief were assessed post-procedure.
Main Results:
- Uterine artery embolisation resulted in a mean uterine volume reduction of 29%-51% at three months, with continued shrinkage observed in longer follow-ups.
- Symptomatic relief, particularly of pelvic pressure, was achieved in 91%-96% of women.
- A small risk of complications requiring hysterectomy exists, and the long-term effects on ovarian function remain unknown.
Conclusions:
- Uterine artery embolisation is an effective treatment for symptomatic fibroids, offering significant symptom relief.
- While uterine volume reduction is variable, UAE provides a viable alternative to surgery with a favorable symptom relief profile.
- Further research is needed to fully understand the long-term impact of UAE on ovarian function.